ATENOLOL; CHLORTHALIDONE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for atenolol; chlorthalidone and what is the scope of patent protection?
Atenolol; chlorthalidone
is the generic ingredient in three branded drugs marketed by Aurobindo Pharma Usa, Nostrum Labs, Novitium Pharma, Pliva, Sun Pharm Industries, Twi Pharms, Unichem, Watson Labs, and Zydus Pharms, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.Eleven suppliers are listed for this compound.
Summary for ATENOLOL; CHLORTHALIDONE
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 9 |
| NDAs: | 10 |
| Finished Product Suppliers / Packagers: | 11 |
| Clinical Trials: | 4 |
| DailyMed Link: | ATENOLOL; CHLORTHALIDONE at DailyMed |
Recent Clinical Trials for ATENOLOL; CHLORTHALIDONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Federico II University | Phase 4 |
| Agenzia Italiana del Farmaco | Phase 4 |
| VA Office of Research and Development |
Pharmacology for ATENOLOL; CHLORTHALIDONE
| Drug Class | Thiazide-like Diuretic beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
| Physiological Effect | Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for ATENOLOL; CHLORTHALIDONE
US Patents and Regulatory Information for ATENOLOL; CHLORTHALIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Twi Pharms | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 072302-002 | May 31, 1990 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 210028-001 | Mar 8, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 210028-002 | Mar 8, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nostrum Labs | ATENOLOL AND CHLORTHALIDONE | atenolol; chlorthalidone | TABLET;ORAL | 074404-002 | May 14, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ATENOLOL; CHLORTHALIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Twi Pharms | TENORETIC 50 | atenolol; chlorthalidone | TABLET;ORAL | 018760-002 | Jun 8, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Twi Pharms | TENORETIC 50 | atenolol; chlorthalidone | TABLET;ORAL | 018760-002 | Jun 8, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| Twi Pharms | TENORETIC 50 | atenolol; chlorthalidone | TABLET;ORAL | 018760-002 | Jun 8, 1984 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
